Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lauren M. Dembeck
Observed names:
Dembeck, Lauren M,
Lauren M Dembeck,
M. Dembeck, Lauren
Institution:
North Carolina State University
Observed institution:
North Carolina State University
OpenAlex ID:
A5080635560
Genetic architecture of natural variation in cuticular hydrocarbon composition in Drosophila melanogaster
2015
·
Lauren M Dembeck
, Katalin Böröczky
, et al.
·
eLife
·
157
Mate Preference Across the Speciation Continuum in a Clade of Mimetic Butterflies
2011
·
Richard M. Merrill
, Zachariah Gompert
, et al.
·
Evolution
·
138
Genetic Architecture of Abdominal Pigmentation in Drosophila melanogaster
2015
·
Lauren M. Dembeck
, Wen Huang
, et al.
·
PLoS Genetics
·
102
PDF
Obp56hModulates Mating Behavior inDrosophila melanogaster
2016
·
John R Shorter
, Lauren M Dembeck
, et al.
·
G3 Genes Genomes Genetics
·
42
Genetic basis of natural variation in body pigmentation inDrosophila melanogaster
2015
·
Lauren M Dembeck
, Wen Huang
, et al.
·
Fly
·
16
PDF
Genetic basis of natural variation in body pigmentation in Drosophila melanogaster
2015
·
Dembeck, Lauren M
, Huang, Wen
, et al.
·
Figshare
·
1
Long-Term Outcomes of Dabrafenib/Trametinib in BRAF V600–Mutated Advanced Melanoma
2019
·
Lauren M. Dembeck
CheckMate 204: New First-Line Therapy for Asymptomatic Melanoma Brain Metastases?
2019
·
Lauren M. Dembeck
Outcomes With Experimental Neoadjuvant T-VEC in Resectable Stage IIIB-IVM1a Melanoma
2019
·
Lauren M. Dembeck
Phase III Trial Results May Be Practice-Changing for Melanoma Brain Metastases
2019
·
Lauren M. Dembeck
Updated Results from COLUMBUS Continue to Show Benefits for BRAF V600–Mutant Melanoma
2019
·
Lauren M. Dembeck
COMBI-i Regimen Shows Promise for Patients With BRAF V600–Mutant Melanoma
2019
·
Lauren M. Dembeck
Investigators Are Assessing an Experimental Interleukin-2 Drug in Patients With Metastatic Melanoma
2019
·
Lauren M. Dembeck
Is Pregnancy Safe Following Breast Cancer for Patients With a BRCA Mutation
2019
·
Lauren M. Dembeck
KEYNOTE-029: Alternate Doses of Ipilimumab Show Similar Results in Advanced Melanoma
2019
·
Lauren M. Dembeck
ILLUMINATE 301 Will Study Experimental Immunotherapy for Patients With Advanced Melanoma
2019
·
Lauren M. Dembeck
Will Adjuvant Pembrolizumab Be an Effective Therapy for High-Risk Melanoma?
2019
·
Lauren M. Dembeck
Patient-Reported Quality of Life Maintained With Immunotherapy for Advanced Melanoma
2019
·
Lauren M. Dembeck
Can Adding Bevacizumab Improve Outcomes in Mucosal Melanoma
2019
·
Lauren M. Dembeck
Does Oxaliplatin Improve Survival Over Cisplatin in Advanced Gastric Cancer
2019
·
Lauren M. Dembeck
First Phase III Trial Validates Biomarker-Selected Therapy for Pancreatic Cancer
2019
·
Lauren M. Dembeck
Pembrolizumab as First-Line Therapy in Recurrent/Metastatic Head and Neck Cancer?
2019
·
Lauren M. Dembeck
VISNU-1: FOLFOXIRI vs FOLFOX as First-Line Treatment in Metastatic Colorectal Cancer
2019
·
Lauren M. Dembeck
First-Line Cabazitaxel Proves Beneficial in Patients With Metastatic Prostate Cancer
2019
·
Lauren M. Dembeck
Apalutamide Plus ADT Shows Benefit in Castration-Sensitive Prostate Cancer
2019
·
Lauren M. Dembeck
Show more works
View as search
Works count:
32
Citation count:
456
H-index:
5
I10-index:
5
Year
Topic
Type